Preeclampsia Preeclampsia complicates 2 to 4% of all pregnancies and accounts for about
46,000 maternal deaths and 500,000 fetal or newborn deaths each year. Antihypertensive …

The concept that preeclampsia is a multisystemic syndrome is appreciated in both research
and clinical care. Our understanding of pathophysiology recognizes the role of inflammation …

All units managing hypertensive pregnant women should maintain and review uniform
departmental management protocols and conduct regular audits of maternal & fetal …

Background Among women with hypertensive disorders of pregnancy, biomarkers may
stratify risk for develo** preeclampsia with severe features (sPE). Methods Across 18 US …

Hypertensive disorders of pregnancy (HDP) are one of the most commonly occurring
complications of pregnancy and include chronic hypertension, gestational hypertension, and …

Background Calcium supplementation reduces the risk of pre‐eclampsia, but questions
remain about the dosage to prescribe and who would benefit most. Objectives To evaluate …

Preeclampsia, a multisystem disorder in pregnancy, is still one of the main causes of
maternal morbidity and mortality. Due to a lack of a causative therapy, an accurate prediction …

OBJECTIVE: To systematically review the performance of soluble fms-like tyrosine kinase-1
(sFlt-1), placental growth factor (PlGF), and the sFlt-1/PlGF ratio in predicting adverse …

Objective To determine the relative burdens of maternal and perinatal complications for
preterm and term pre‐eclampsia. Design Prospective observational cohort study. Setting …

Background Any definition of preeclampsia should identify women and babies at greatest
risk of adverse outcomes. Objective This study aimed to investigate the ability of the …